Impact of Specialised Renal Care in Patients With Chronic Kidney Disease
Not Applicable
Completed
- Conditions
- Chronic Kidney Disease
- Interventions
- Behavioral: specialised renal care
- Registration Number
- NCT00929760
- Lead Sponsor
- Patrick Saudan
- Brief Summary
This is a prospective randomised trial studying patients with stage 3 to 5 chronic kidney disease (CKD) in order to determine the impact of specialised care by nephrologists compared to guidelines-directed management by primary care physicians (PCP) on: a) prognosis (clinical outcome), b) planning of renal replacement therapy (RRT) (urgent versus planned initiation RRT) and c) patient satisfaction.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 242
Inclusion Criteria
- Patients with CKD stage 3, 4 and 5 (CCl < 40 ml/min according to abbreviated MDRD formula) aged 18-80 years old and enrolled during a hospitalization.
Exclusion Criteria
- Patients previously known by nephrologists.
- Estimated life expectancy < 1 year
- Refusal or inability to sign writing consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description nephrologists specialised renal care Combined management PCP: nephrologists (at least 4 nephrology visits/year) Primary Care Physicians specialised renal care Management by PCPs only, with the help of written instructions from our nephrology unit based on EBPG
- Primary Outcome Measures
Name Time Method Primary (composite): death, and hospitalisation 24 months after enrollment death and emergency hospitalisation during the following 2 years afterr andomisation
- Secondary Outcome Measures
Name Time Method Secondary: initiation of urgent RRT, decline of renal residual function at 2 years, decline of quality of life 24 months after enrollment cf title
Trial Locations
- Locations (1)
Nephrology Unit Geneva University Hospitals
🇨🇭Geneva, Geneva City, Switzerland